retatrutide phase 2 nejm 2023 obesity trial results study sees significant weight loss in drug study Retatrutide Phase 2 NEJM Trial:

Based on clinical trial data, tirzepatide produces superior weight loss results, but the better medication depends on individual factors beyond just numbers

6 BILLION CFU WITH 16 STRAINS FOR WOMEN AND MEN: Formulated for both women and men, each capsule delivers 6 billion CFU from a diverse blend of 16 probiotic strains selected to support everyday gut balance and microbiome diversity

All this is to say that we would expect the prevalence of coverage of GLP-1s in the individual market to be quite low compared to the self-insured employer market

Retatrutide Dosing Schedule Weekly Administration Most research protocols use once-weekly injections

Peptides may be considered as part of a broader treatment approach that includes nutrition, physical activity, and medical evaluation

BHUs GLP-1 friendly bars are the one bar that consistently hits the mark for people balancing diet, energy, and flavor